Simon has over six years of professional trading experience across FX, commodities and equities. He has a strong passion for financial markets and is particularly focused on price action trading
Aethlon Medical, Inc. (NASDAQ: AEMD) stock rallied 44.73% during premarket trading despite not making any announcements today, in what some are calling a short squeeze.
However, the company’s shares are not widely shorted; hence, today’s rally could be more of a pump and dump instead of a short squeeze.
The last significant news from Aethlon was the release of its disappointing Q1 earnings results on August 9, 2021, where it generated revenue worth $131,966, missing analysts consensus estimates of $200,000.
Since then, there has been little activity in AEMD stock, which has largely traded sideways up to now. Furthermore, most of the company’s revenues were from government contracts, and it is yet to announce any new contracts.
Retail investors should be careful trading this stock, given the lack of fundamental drivers to fuel a rally higher unless we get further news after the market opens.
Over 3.4 million Aethlon Medical shares had changed hands at writing compared to its normal average daily traded volume of 312,454.
Aethlon Medical stock price.
Aethlon Medical shares 44.73% to trade at $5.50, rising from Tuesday’s closing price of $3.80.
One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It's a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .